Home / Recalls / SCA Pharmaceuticals, LLC / D-0422-2024

D-0422-2024 Class II Terminated

Recalled by SCA Pharmaceuticals, LLC — Windsor, CT

FDA drug recall D-0422-2024 was initiated by SCA Pharmaceuticals, LLC on Nov 9, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Aug 27, 2024). Affected quantity: 9,624 syringes.

Recall Details

Product Type: Drugs
Report Date: Apr 3, 2024
Initiation Date: Nov 9, 2023
Termination Date: Aug 27, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 9,624 syringes

Product Description

Sodium Citrate 4% 3 mL, Anticoagulation Solution Injection (Concentration = 40/mg/mL) 3mL fill Syringe, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0900-25, Bar Code 70004090025

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: 1223048444 Exp 11/20/23; 1223049011 Exp 12/12/23; 1223049673 Exp 01/09/24; 1223049771 Exp 01/12/24

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0422-2024
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by SCA Pharmaceuticals, LLC

D-0417-2024 Class II — PHENYLephrine HCl 5000 mcg/50 mL in 0.9% Sodium Chloride Injection… (Nov 9, 2023)
D-0411-2024 Class II — labetalol HCl 20 mg/4mL Injection, (Concentration=5 mg/mL), 4 mL fill Syringe… (Nov 9, 2023)
D-0396-2024 Class II — fentaNYL 2,500 mcg/50 mL Injection (Concentration = 50 mcg/mL), INTRAVENOUS USE… (Nov 9, 2023)
D-0414-2024 Class II — PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride Injection… (Nov 9, 2023)
D-0405-2024 Class II — HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration =… (Nov 9, 2023)
D-0401-2024 Class II — fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL… (Nov 9, 2023)
D-0410-2024 Class II — HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration… (Nov 9, 2023)
D-0416-2024 Class II — PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration… (Nov 9, 2023)
D-0400-2024 Class II — fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.04% in 0.9% Sodium Chloride 100 mL… (Nov 9, 2023)
D-0423-2024 Class II — SUCcinylcholine Chloride 200 mg/10mL Injection (Concentration = 20mg/mL), 10 mL… (Nov 9, 2023)